Show simple item record

dc.contributor.authorBrun, Vegard Heimly
dc.contributor.authorEriksen, Amund H.
dc.contributor.authorSelseth, Ruth
dc.contributor.authorJohansson, Kenth
dc.contributor.authorVik, Renate
dc.contributor.authorDavidsen, Benedicte
dc.contributor.authorKaut, Michal
dc.contributor.authorHellemo, Lars
dc.date.accessioned2022-05-09T07:31:38Z
dc.date.available2022-05-09T07:31:38Z
dc.date.created2021-10-08T18:31:47Z
dc.date.issued2021
dc.identifier.citationThyroid. 2021, 31 (9), 1297-1304.en_US
dc.identifier.issn1050-7256
dc.identifier.urihttps://hdl.handle.net/11250/2994667
dc.language.isoengen_US
dc.publisherMary Ann Liebert, Inc.en_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.subjectthyroidectomyen_US
dc.subjectpharmacokinetic modelingen_US
dc.subjectpatient tailoreden_US
dc.subjectlevothyroxine dosageen_US
dc.subjectdecision aid toolen_US
dc.titlePatient-tailored levothyroxine dosage with pharmacokinetic/pharmacodynamic modeling: A novel approach after total thyroidectomyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holderª Vegard Heimly Brun et al., 2021; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License [CC-BY-NC] (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are cited.en_US
dc.source.pagenumber1297-1304en_US
dc.source.volume31en_US
dc.source.journalThyroiden_US
dc.source.issue9en_US
dc.identifier.doi10.1089/thy.2021.0125
dc.identifier.cristin1944535
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell 4.0 Internasjonal